Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes
CNS Drugs journal brought out the study that aimed to assess whether antipsychotic use during pregnancy is associated with gestational diabetes and found that drugs like Olanzapine, clozapine and quetiapine used during pregnancy were associated with increased risks for gestational diabetes and the infant being large for gestational age.
A Swedish national register‐based cohort study included over 1 lac singleton births. Antipsychotics were divided into 728 first-generation antipsychotics, 1710 in high-risk metabolic second-generation antipsychotics including olanzapine, clozapine and quetiapine, and 541 in other second-generation antipsychotics. The risks for gestational diabetes, foetal growth disturbances, pre-eclampsia, caesarean section and preterm labour were assessed. Women treated during pregnancy were compared to women not treated during pregnancy and to women who used antipsychotics before/after but not during pregnancy.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.